Europe Clinical Trials Market 2021-2031 by Product Category (Drugs, Devices, Procedures), Phase (I, II, III, IV), Design (Interventional, Observational, Expanded Access), Service Type (Site Identification, Lab Services, Supply & Logistic, Decentralized Services), Indication (Oncology, Infectious Diseases, Cardiology, Obesity, Diabetes, Neurology), End User, and Country: Trend Forecast and Growth Opportunity

About the Report

About the Report

Europe clinical trials market was valued at USD10,471.1 million in 2021 and will grow by 6.2% annually over 2021-2031, driven by the increasing number of clinical trials and increase in demand for novel therapies, rising prevalence on chronic diseases such as cancer and diabetes, the outbreak of tropical and infectious diseases such as COVID-19, and the increase in government initiatives and R&D investments.

Highlighted with 39 tables and 79 figures, this 142-page report Europe Clinical Trials Market 2021-2031 by Product Category (Drugs, Devices, Procedures), Phase (I, II, III, IV), Design (Interventional, Observational, Expanded Access), Service Type (Site Identification, Lab Services, Supply & Logistic, Decentralized Services), Indication (Oncology, Infectious Diseases, Cardiology, Obesity, Diabetes, Neurology), End User, and Country: Trend Forecast and Growth Opportunity is based on a comprehensive research of the entire Europe clinical trials market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:

Market Structure

Growth Drivers

Restraints and Challenges

Emerging Product Trends & Market Opportunities

Porter's Fiver Forces

The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Europe clinical trials market in every aspect of the classification from perspectives of Product Category, Phase, Design, Service Type, Indication, End User, and Country.

Based on Product Category, the Europe market is segmented into the following sub-markets with annual revenue (USD mn) for 2021-2031 included in each section.

Trials of Drugs

o Small Molecule Drugs

o Vaccines

o Cell & Gene Therapy

o Other Drugs

Trials of Devices

Trials of Procedures

Based on Phase, the Europe market is segmented into the following sub-markets with annual revenue (USD mn) for 2021-2031 included in each section.

Phase I

Phase II

Phase III

Phase IV

By Design, the Europe market is segmented into the following sub-markets with annual revenue (USD mn) for 2021-2031 included in each section.

Interventional Studies

o Randomized Control Trial

o Adaptive Clinical Trial

o Non-randomized Control Trial

Observational Studies

o Cohort Study

o Case Control Study

o Cross Sectional Study

o Ecological Study

Expanded Access Trials

By Service Type, the Europe market is segmented into the following sub-markets with annual revenue (USD mn) for 2021-2031 included in each section.

Protocol Designing

Site Identification

Patient Recruitment

Laboratory Services

Bioanalytical Testing Services

Clinical Trial Data Management Services

Clinical Trial Supply & Logistic Services

Decentralized Clinical Trial Services

Medical Device Testing Services

Other Clinical Trial Services

By Indication, the Europe market is segmented into the following sub-markets with annual revenue (USD mn) for 2021-2031 included in each section.

Oncology

Infectious Diseases

Cardiology

Obesity

Diabetes

Neurology

Immunology

Pain Management

Other Indications

By End User, the Europe market is segmented into the following sub-markets with annual revenue (USD mn) for 2021-2031 included in each section.

Pharmaceutical and Biotechnological Companies

Clinical Research Organizations

Clinical Testing Laboratories

Other End Users

Geographically, the following national/local markets are fully investigated:

Germany

UK

France

Spain

Italy

Russia

Rest of Europe (further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)

For each key country, detailed analysis and data for annual revenue (USD mn) are available for 2021-2031. The breakdown of national markets by Phase, Design, and Indication over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Selected Key Players:

Accell Clinical Research LLC

Charles River Laboratory

ClinDatrix Inc

Clinipace

Eli Lilly and Company

F. Hoffmann-La Roche Ltd.

ICON PLC

IQVIA Holdings, Inc.

Laboratory Corporation of America

Novo Nordisk AS

PAREXEL International Corporation

Pfizer Inc.

Pharmaceutical Product Development LLC

PRA Health Sciences

Sanofi SA

SGS SA

Syneos Health Inc.

Wuxi AppTec Inc.

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Products


Companies

Selected Key Players:

Accell Clinical Research LLC

Charles River Laboratory

ClinDatrix Inc

Clinipace

Eli Lilly and Company

F. Hoffmann-La Roche Ltd.

ICON PLC

IQVIA Holdings, Inc.

Laboratory Corporation of America

Novo Nordisk AS

PAREXEL International Corporation

Pfizer Inc.

Pharmaceutical Product Development LLC

PRA Health Sciences

Sanofi SA

SGS SA

Syneos Health Inc.

Wuxi AppTec Inc.

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Table of Contents

Table of Contents

1 Introduction 7

1.1 Industry Definition and Research Scope 7

1.1.1 Industry Definition 7

1.1.2 Research Scope 8

1.2 Research Methodology 11

1.2.1 Overview of Market Research Methodology 11

1.2.2 Market Assumption 12

1.2.3 Secondary Data 12

1.2.4 Primary Data 12

1.2.5 Data Filtration and Model Design 13

1.2.6 Market Size/Share Estimation 14

1.2.7 Research Limitations 15

1.3 Executive Summary 16

2 Market Overview and Dynamics 19

2.1 Market Size and Forecast 19

2.1.1 Impact of COVID-19 on World Economy 21

2.1.2 Impact of COVID-19 on the Market 23

2.2 Major Growth Drivers 25

2.3 Market Restraints and Challenges 32

2.4 Emerging Opportunities and Market Trends 35

2.5 Porter's Fiver Forces Analysis 39

3 Segmentation of Europe Market by Product Category 43

3.1 Market Overview by Product Category 43

3.2 Trials of Drugs 45

3.2.1 Small Molecule Drugs 46

3.2.2 Vaccines 47

3.2.3 Cell & Gene Therapy 48

3.2.4 Other Drugs 49

3.3 Trials of Devices 50

3.4 Trials of Procedures 51

4 Segmentation of Europe Market by Phase 52

4.1 Market Overview by Phase 52

4.2 Phase I 54

4.3 Phase II 55

4.4 Phase III 56

4.5 Phase IV 57

5 Segmentation of Europe Market by Design 58

5.1 Market Overview by Design 58

5.2 Interventional Studies 60

5.2.1 Randomized Control Trial 62

5.2.2 Adaptive Clinical Trial 63

5.2.3 Non-randomized Control Trial 64

5.3 Observational Studies 65

5.3.1 Cohort Study 67

5.3.2 Case Control Study 68

5.3.3 Cross Sectional Study 69

5.3.4 Ecological Study 70

5.4 Expanded Access Trials 71

6 Segmentation of Europe Market by Service Type 72

6.1 Market Overview by Service Type 72

6.2 Protocol Designing 74

6.3 Site Identification 75

6.4 Patient Recruitment 76

6.5 Laboratory Services 77

6.6 Bioanalytical Testing Services 78

6.7 Clinical Trial Data Management Services 79

6.8 Clinical Trial Supply & Logistic Services 80

6.9 Decentralized Clinical Trial Services 81

6.10 Medical Device Testing Services 82

6.11 Other Clinical Trial Services 83

7 Segmentation of Europe Market by Indication 84

7.1 Market Overview by Indication 84

7.2 Oncology 86

7.3 Infectious Diseases 87

7.4 Cardiology 88

7.5 Obesity 89

7.6 Diabetes 90

7.7 Neurology 91

7.8 Immunology 92

7.9 Pain Management 93

7.10 Other Indications 94

8 Segmentation of Europe Market by End User 95

8.1 Market Overview by End User 95

8.2 Pharmaceutical and Biotechnological Companies 97

8.3 Clinical Research Organizations 98

8.4 Clinical Testing Laboratories 99

8.5 Other End Users 100

9 European Market 2021-2031 by Country 101

9.1 Overview of European Market 101

9.2 Germany 104

9.3 U.K. 106

9.4 France 108

9.5 Spain 110

9.6 Italy 112

9.7 Russia 114

9.8 Rest of European Market 116

10 Competitive Landscape 118

10.1 Overview of Key Vendors 118

10.2 New Product Launch, Partnership, Investment, and M&A 122

10.3 Company Profiles 123

Accell Clinical Research LLC 123

Charles River Laboratory 125

ClinDatrix Inc 126

Clinipace 127

Eli Lilly and Company 128

F. Hoffmann-La Roche Ltd. 129

ICON PLC 130

IQVIA Holdings, Inc. 131

Laboratory Corporation of America 132

Novo Nordisk AS 133

PAREXEL International Corporation 134

Pfizer Inc. 135

Pharmaceutical Product Development LLC 136

PRA Health Sciences 137

Sanofi SA 138

SGS SA 139

Syneos Health Inc. 140

Wuxi AppTec Inc. 141

RELATED REPORTS 142


List of Figure

List of Figures:

Figure 1. Research Method Flow Chart 11

Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 14

Figure 3. Europe Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031 16

Figure 4. Europe Clinical Trials Market, 2021-2031, USD mn 19

Figure 5. Impact of COVID-19 on Business 23

Figure 6. Primary Drivers and Impact Factors of Europe Clinical Trials Market 25

Figure 7. Percentage of Trial Participants by Country, 2015-2019 28

Figure 8. Leading Causes of Death in the World, 2019-2020, million 29

Figure 9. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 30

Figure 10. World Population 65 and Over, % of Total Population, 1950-2060 30

Figure 11. Primary Restraints and Impact Factors of Europe Clinical Trials Market 32

Figure 12. Investment Opportunity Analysis 36

Figure 13. Porter's Fiver Forces Analysis of Europe Clinical Trials Market 39

Figure 14. Breakdown of Europe Clinical Trials Market by Product Category, 2021-2031, % of Revenue 44

Figure 15. Europe Addressable Market Cap in 2022-2031 by Product Category, Value (USD mn) and Share (%) 44

Figure 16. Europe Clinical Trials Market by Product Category: Trials of Drugs, 2021-2031, USD mn 45

Figure 17. Europe Clinical Trials Market by Trials of Drugs: Small Molecule Drugs, 2021-2031, USD mn 46

Figure 18. Europe Clinical Trials Market by Trials of Drugs: Vaccines, 2021-2031, USD mn 47

Figure 19. Europe Clinical Trials Market by Trials of Drugs: Cell & Gene Therapy, 2021-2031, USD mn 48

Figure 20. Europe Clinical Trials Market by Trials of Drugs: Other Drugs, 2021-2031, USD mn 49

Figure 21. Europe Clinical Trials Market by Product Category: Trials of Devices, 2021-2031, USD mn 50

Figure 22. Europe Clinical Trials Market by Product Category: Trials of Procedures, 2021-2031, USD mn 51

Figure 23. Breakdown of Europe Clinical Trials Market by Phase, 2021-2031, % of Sales Revenue 53

Figure 24. Europe Addressable Market Cap in 2022-2031 by Phase, Value (USD mn) and Share (%) 53

Figure 25. Europe Clinical Trials Market by Phase: Phase I, 2021-2031, USD mn 54

Figure 26. Europe Clinical Trials Market by Phase: Phase II, 2021-2031, USD mn 55

Figure 27. Europe Clinical Trials Market by Phase: Phase III, 2021-2031, USD mn 56

Figure 28. Europe Clinical Trials Market by Phase: Phase IV, 2021-2031, USD mn 57

Figure 29. Breakdown of Europe Clinical Trials Market by Design, 2021-2031, % of Sales Revenue 59

Figure 30. Europe Addressable Market Cap in 2022-2031 by Design, Value (USD mn) and Share (%) 59

Figure 31. Europe Clinical Trials Market by Design: Interventional Studies, 2021-2031, USD mn 60

Figure 32. Europe Clinical Trials Market by Interventional Studies: Randomized Control Trial, 2021-2031, USD mn 62

Figure 33. Europe Clinical Trials Market by Interventional Studies: Adaptive Clinical Trial, 2021-2031, USD mn 63

Figure 34. Europe Clinical Trials Market by Interventional Studies: Non-randomized Control Trial, 2021-2031, USD mn 64

Figure 35. Europe Clinical Trials Market by Design: Observational Studies, 2021-2031, USD mn 65

Figure 36. Europe Clinical Trials Market by Observational Studies: Cohort Study, 2021-2031, USD mn 67

Figure 37. Europe Clinical Trials Market by Observational Studies: Case Control Study, 2021-2031, USD mn 68

Figure 38. Europe Clinical Trials Market by Observational Studies: Cross Sectional Study, 2021-2031, USD mn 69

Figure 39. Europe Clinical Trials Market by Observational Studies: Ecological Study, 2021-2031, USD mn 70

Figure 40. Europe Clinical Trials Market by Design: Expanded Access Trials, 2021-2031, USD mn 71

Figure 41. Breakdown of Europe Clinical Trials Market by Service Type, 2021-2031, % of Revenue 73

Figure 42. Europe Addressable Market Cap in 2022-2031 by Service Type, Value (USD mn) and Share (%) 73

Figure 43. Europe Clinical Trials Market by Service Type: Protocol Designing, 2021-2031, USD mn 74

Figure 44. Europe Clinical Trials Market by Service Type: Site Identification, 2021-2031, USD mn 75

Figure 45. Europe Clinical Trials Market by Service Type: Patient Recruitment, 2021-2031, USD mn 76

Figure 46. Europe Clinical Trials Market by Service Type: Laboratory Services, 2021-2031, USD mn 77

Figure 47. Europe Clinical Trials Market by Service Type: Bioanalytical Testing Services, 2021-2031, USD mn 78

Figure 48. Europe Clinical Trials Market by Service Type: Clinical Trial Data Management Services, 2021-2031, USD mn 79

Figure 49. Europe Clinical Trials Market by Service Type: Clinical Trial Supply & Logistic Services, 2021-2031, USD mn 80

Figure 50. Europe Clinical Trials Market by Service Type: Decentralized Clinical Trial Services, 2021-2031, USD mn 81

Figure 51. Europe Clinical Trials Market by Service Type: Medical Device Testing Services, 2021-2031, USD mn 82

Figure 52. Europe Clinical Trials Market by Service Type: Other Clinical Trial Services, 2021-2031, USD mn 83

Figure 53. Breakdown of Europe Clinical Trials Market by Indication, 2021-2031, % of Revenue 85

Figure 54. Europe Addressable Market Cap in 2022-2031 by Indication, Value (USD mn) and Share (%) 85

Figure 55. Europe Clinical Trials Market by Indication: Oncology, 2021-2031, USD mn 86

Figure 56. Europe Clinical Trials Market by Indication: Infectious Diseases, 2021-2031, USD mn 87

Figure 57. Europe Clinical Trials Market by Indication: Cardiology, 2021-2031, USD mn 88

Figure 58. Europe Clinical Trials Market by Indication: Obesity, 2021-2031, USD mn 89

Figure 59. Europe Clinical Trials Market by Indication: Diabetes, 2021-2031, USD mn 90

Figure 60. Europe Clinical Trials Market by Indication: Neurology, 2021-2031, USD mn 91

Figure 61. Europe Clinical Trials Market by Indication: Immunology, 2021-2031, USD mn 92

Figure 62. Europe Clinical Trials Market by Indication: Pain Management, 2021-2031, USD mn 93

Figure 63. Europe Clinical Trials Market by Indication: Other Indications, 2021-2031, USD mn 94

Figure 64. Breakdown of Europe Clinical Trials Market by End User, 2021-2031, % of Revenue 95

Figure 65. Europe Addressable Market Cap in 2022-2031 by End User, Value (USD mn) and Share (%) 96

Figure 66. Europe Clinical Trials Market by End User: Pharmaceutical and Biotechnological Companies, 2021-2031, USD mn 97

Figure 67. Europe Clinical Trials Market by End User: Clinical Research Organizations, 2021-2031, USD mn 98

Figure 68. Europe Clinical Trials Market by End User: Clinical Testing Laboratories, 2021-2031, USD mn 99

Figure 69. Europe Clinical Trials Market by End User: Other End Users, 2021-2031, USD mn 100

Figure 70. Breakdown of European Clinical Trials Market by Country, 2021 and 2031, % of Revenue 102

Figure 71. Contribution to Europe 2022-2031 Cumulative Market by Country, Value (USD mn) and Share (%) 103

Figure 72. Clinical Trials Market in Germany, 2021-2031, USD mn 104

Figure 73. Clinical Trials Market in U.K., 2021-2031, USD mn 106

Figure 74. Clinical Trials Market in France, 2021-2031, USD mn 108

Figure 75. Clinical Trials Market in Spain, 2021-2031, USD mn 110

Figure 76. Clinical Trials Market in Italy, 2021-2031, USD mn 112

Figure 77. Clinical Trials Market in Russia, 2021-2031, USD mn 114

Figure 78. Clinical Trials Market in Rest of Europe, 2021-2031, USD mn 116

Figure 79. Growth Stage of Europe Clinical Trials Industry over the Forecast Period 118


List of Table

List of Tables:

Table 1. Snapshot of Europe Clinical Trials Market in Balanced Perspective, 2021-2031 17

Table 2. Total Number of Registered Clinical Studies Worldwide, 2010-2021 20

Table 3. World Economic Outlook, 2021-2031 22

Table 4. World Health Spending by Region, USD bn, 2013-2020 31

Table 5. Main Product Trends and Market Opportunities in Europe Clinical Trials Market 35

Table 6. Europe Clinical Trials Market by Product Category, 2021-2031, USD mn 43

Table 7. Europe Clinical Trials Market: Trials of Drugs by Drug Type, 2021-2031, USD mn 45

Table 8. Europe Clinical Trials Market by Phase, 2021-2031, USD mn 52

Table 9. Europe Clinical Trials Market by Design, 2021-2031, USD mn 58

Table 10. Europe Clinical Trials Market: Interventional Studies by Segment, 2021-2031, USD mn 61

Table 11. Europe Clinical Trials Market: Observational Studies by Segment, 2021-2031, USD mn 66

Table 12. Europe Clinical Trials Market by Service Type, 2021-2031, USD mn 72

Table 13. Europe Clinical Trials Market by Indication, 2021-2031, USD mn 84

Table 14. Europe Clinical Trials Market by End User, 2021-2031, USD mn 95

Table 15. Europe Clinical Trials Market by Country, 2021-2031, USD mn 103

Table 16. Germany Clinical Trials Market by Phase, 2021-2031, USD mn 105

Table 17. Germany Clinical Trials Market by Design, 2021-2031, USD mn 105

Table 18. Germany Clinical Trials Market by Indication, 2021-2031, USD mn 105

Table 19. U.K. Clinical Trials Market by Phase, 2021-2031, USD mn 107

Table 20. U.K. Clinical Trials Market by Design, 2021-2031, USD mn 107

Table 21. U.K. Clinical Trials Market by Indication, 2021-2031, USD mn 107

Table 22. France Clinical Trials Market by Phase, 2021-2031, USD mn 109

Table 23. France Clinical Trials Market by Design, 2021-2031, USD mn 109

Table 24. France Clinical Trials Market by Indication, 2021-2031, USD mn 109

Table 25. Spain Clinical Trials Market by Phase, 2021-2031, USD mn 111

Table 26. Spain Clinical Trials Market by Design, 2021-2031, USD mn 111

Table 27. Spain Clinical Trials Market by Indication, 2021-2031, USD mn 111

Table 28. Italy Clinical Trials Market by Phase, 2021-2031, USD mn 113

Table 29. Italy Clinical Trials Market by Design, 2021-2031, USD mn 113

Table 30. Italy Clinical Trials Market by Indication, 2021-2031, USD mn 113

Table 31. Russia Clinical Trials Market by Phase, 2021-2031, USD mn 115

Table 32. Russia Clinical Trials Market by Design, 2021-2031, USD mn 115

Table 33. Russia Clinical Trials Market by Indication, 2021-2031, USD mn 115

Table 34. Clinical Trials Market in Rest of Europe by Country, 2021-2031, USD mn 117

Table 35. Percentage of Registered Studies by Location (as of February 24, 2022) 120

Table 36. Percentage of Recruiting Studies by Location (as of February 24, 2022) 120

Table 37. Accell Clinical Research LLC: Company Snapshot 123

Table 38. Accell Clinical Research LLC: Business Segmentation 124

Table 39. Accell Clinical Research LLC: Product Portfolio 124

You can also purchase parts of this report. Do you want to check out a section wise price list?

Why Buy From US?

RRR
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

reach
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Research
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

Insite
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository
150+ Consulting project a year
100+ Analysts
8000+ Client Queries in 2022

What Our Clients Say About Us

Want the same for your business? Talk To Our Expert